United Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UTHR and other ETFs, options, and stocks.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.

CEO

Martine A. Rothblatt

CEOMartine A. Rothblatt

Employees

1,168

Employees1,168

Headquarters

Silver Spring, Maryland

HeadquartersSilver Spring, Maryland

Founded

1996

Founded1996

Employees

1,168

Employees1,168

UTHR Key Statistics

Market cap

15.79B

Market cap15.79B

Price-Earnings ratio

15.56

Price-Earnings ratio15.56

Dividend yield

—

Dividend yield—

Average volume

338.37K

Average volume338.37K

High today

$356.57

High today$356.57

Low today

$351.29

Low today$351.29

Open price

$355.15

Open price$355.15

Volume

466.42K

Volume466.42K

52 Week high

$417.82

52 Week high$417.82

52 Week low

$208.62

52 Week low$208.62

UTHR News

TipRanks 4d

United Therapeutics announces FDA clearance of UKidney NDA

United Therapeutics (UTHR) announced that the FDA has cleared its investigational new drug application to initiate a clinical study of the company’s investigati...

Analyst ratings

56%

of 16 ratings

Buy

56.3%

Hold

37.5%

Sell

6.3%